Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
continuous glucose monitor
MedTech
Glucotrack’s 3-year diabetes sensor implant clears human trial
Glucotrack has cleared the first human clinical study of its long-term CGM implant, designed to live under the skin for as long as three years.
Conor Hale
Feb 5, 2025 11:30am
Schools aren’t plugged in to kids’ diabetes tech, parents say
Jan 30, 2025 10:51am
Abbott posts device sales gains after heart valve, CGM debuts
Jan 22, 2025 10:30am
Dexcom predicts 2025 gains, with Stelo pushing portfolio updates
Jan 14, 2025 10:45am
Abbott, Dexcom agree to 10-year truce over CGM patent litigation
Jan 2, 2025 11:43am
Dexcom pairs gen AI lifestyle tips with its OTC glucose sensor
Dec 17, 2024 12:00pm
